Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma. [electronic resource]
Producer: 20180109Description: 42988-42995 p. digitalISSN:- 1949-2553
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- Cetuximab -- administration & dosage
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Fluorouracil -- administration & dosage
- GTP Phosphohydrolases -- genetics
- Head and Neck Neoplasms -- drug therapy
- High-Throughput Nucleotide Sequencing -- methods
- Humans
- Liquid Biopsy -- methods
- Membrane Proteins -- genetics
- Mutation -- drug effects
- Platinum -- administration & dosage
- Proto-Oncogene Proteins p21(ras) -- genetics
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.